期刊文献+

hTERT mRNA、UbcH10和Ki-67在乳腺大汗腺病变中的鉴别诊断价值 被引量:1

Value of differential diagnosis of hTERT mRNA,UbcH10 and Ki-67 in breast apocrine lesions
下载PDF
导出
摘要 目的探讨UbcH10、Ki-67和hTERT mRNA在乳腺大汗腺病变中的鉴别诊断价值。方法免疫组织化学EnVision法检测标记物UbcH10和Ki-67,显色原位杂交检测hTERT mRNA在20例大汗腺化生(APM)、26例大汗腺腺病(AA)、32例非典型性大汗腺增生(AAH)、22例大汗腺导管内癌(ADCIS)和35浸润性大汗腺癌(IAC)的表达。结果 UbcH10、Ki-67和hTERT mRNA在APM、AA、AAH、ADCIS和IAC表达的阳性率分别为(10.0%、5.0%和45.0%)、(50.0%、50.0%和84.6%)、(62.5%、62.5%和81.3%)、(81.8%、81.8%和81.8%)和(94.3%、94.3%和85.7%),呈正相关。Ki-67在APM、AA、AAH、ADCIS和IAC中表达的平均增殖指数分别为1.01%、5.35%、7.53%、16.05%和31.12%。hTERT mRNA、Ki-67和UbcH10表达的阳性率在APM与AA、AAH、ADCIS和IAC相比较差异具有统计学意义(P<0.05),在AA、AAH、ADCIS和IAC相邻两组比较中差异均无统计学意义(P>0.05);Ki-67平均增殖指数在AA、AAH与ADCIS相比较差异具有统计学意义(P<0.05)。结论苏木精-伊红染色观察组织病理学特征,辅以免疫组织化学方法检测Ki-67,能够在一定程度上提高乳腺大汗腺谱系中良、恶性病变鉴别诊断的准确性。 Objective To investigate the value of UbcH10, Ki-67 and hTERT mRNA in differential diagnosis of breast apocrine lesions. Methods The expression of UbcH10 and Ki-67 was detected by immunohistochemical EnVision method, and the expression of hTERT mRNA was determined by chromogenic in situ hybridization in 20 cases of apocrine metaplasia (APM), 26 cases of apocrine adenosis (AA), 32 cases of atypical apocrine hyperplasia (AAH), 22 cases of apocrine ductal carcinoma in situ (ADCIS) and 35 cases of invasive apocrine carcinoma (IAC). Results The positive expression of UbcH10 in APM, AA, AAH, ADCIS and IAC was 10.0%, 50.0%, 62.5%, 81.8% and 94.3% respectively, that of Ki-67 was 5.0%, 50.0%, 62.5%, 81.8% and 94.3% respectively, and that of hTERTmRNA was 45.0%, 84.6%, 81.3%, 81.8% and 85.7% respectively. The average proliferation index of Ki-67 expression in APM, AA, AAH, ADCIS and IAC was 1.01%, 5.35%, 7.53%, 16.05% and 31. 12% respectively. There were significant differences in the positive expression rates of hTERT mRNA, Ki-67 and UbcH10 between APM and AA, AAH, ADCIS and IAC (P 〈 0.05), while there was no significant difference between two adjacent groups of AA, AAH, ADCIS and IAC (P 〉0.05). There were significant differences in the average proliferation index of Ki-67 among AA, AAH and ADCIS (P 〈0. 05). Conclusion Observing the histopathological characteristics with HE staining and detecting Ki-67 with immunohistochemical method may improve the accuracy of differential diagnosis of benign and malignant lesions in the breast apocrine lineage to some extent.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第9期1239-1243,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市黄浦区科技项目(2011-HGG-03)~~
关键词 乳腺 大汗腺病变 UBCH10 KI-67 hTERTm RNA 免疫组织化学 显色原位杂交 breast apocrine lesions UbcH10 Ki-67 hTERT mRNA immunohistochemistry chromogenic in situhybridization
  • 相关文献

参考文献16

  • 1Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO classification of tumours of the breast[ M]. 4th ed. Lyon: IARC press, 2012.
  • 2O'Malley FP. Non-invasive apocrine lesions of the breast[ J]. Curr Diag Pathol, 2004, 10(3) : 211 -219.
  • 3O'Malley FP, Bane AL. The spectrum of apocrine lesions of the breast[J]. AdvAnat Pathol, 2004, 11(1): 1 -9.
  • 4Seidman JD, Ashton M, Lefkowitz M. Atypical apocrine adenosis of the breast: a clinicopatbologic study of 37 patients with 8.7-year follow-up[J]. Cancer, 1996, 77( 12): 2529 -2537.
  • 5Jones C, Damiani S, Wells D, et al. Molecular cytogenetic comparisonof apocrine hyperplasia and apoerine carcinoma of the breast [J] Am J Pathol, 2001, 158(1) : 207 -214.
  • 6Farmer P, Bonnefoi H, Becette V, et al. Identification of molecular apocrine breast tumours by mieroarray analysis [ J ]. Oncogene, 2005, 24 (29) : 4660 - 4671.
  • 7唐峰,顾栋桦,王虹,朱腾芳,朱虹光,许组德,胡锡琪.端粒酶hTERT mRNA表达在乳腺癌进展中的意义及其与p53的相关性[J].中华肿瘤杂志,2006,28(3):192-195. 被引量:13
  • 8Liu J, Baykal A, Fung KM, et al. Human telomerase reverse tran- scriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ[ J]. Int J Oncol, 2004, 24(4) : 879 -884.
  • 9Elayat G, Selim AG, Wells CA. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast[ J]. Ann Diagn Pathol, 2010, 14(1): 1-7.
  • 10Moriya T, Sakamuto K, Sasano H, et al. Immunohistochemical analysis of Ki:7, p53, p21, and p27 in benign and malignant apocrine lesions of the breast : its correlation to histologic findings in 43 cases[J]. Mod Pathol, 2000, 13(1): 13-18.

二级参考文献12

  • 1Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997,277 : 955-959.
  • 2Ducrest AL, Szutorisz H, Lingner J, et al. Regulation of the human telomerase reverse transcriptase gene. Oncogene, 2002, 21: 541-552.
  • 3Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science,1994, 266 : 2011-2015.
  • 4Kolquist KA, Ellisen LW, Counter CM, et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.Nat Genet, 1998, 19: 182-186.
  • 5Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer, 1997, 33: 787-791.
  • 6Levine AJ. p53, the cellular gatekeeper for growth and division.Cell, 1997, 88: 323-331.
  • 7Gollahon LS, Kraus E, Wu TA, et al. Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene, 1998, 17: 709-717.
  • 8Mukhopadhyay T, Multani AS, Roth JA, et al. Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p.53-mediated apoptosis. Oncogene, 1998, 17 :901-906.
  • 9Xu D, Wang Q, Gruber A, et al. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene, 2000, 19: 5123-5133.
  • 10叶哲伟,陈晓春,童强松,邢毅飞,杨军,候琳,鲁功成.睾丸肿瘤组织中端粒酶RNA成分的表达及其意义[J].中华肿瘤杂志,2003,25(2):171-171. 被引量:1

共引文献12

同被引文献30

  • 1Lee JJ, AU AY, Foukakis T, et al. Array-CGH identifies cyclin D1and UBCH10 amplicons in anaplastic thyroid carcinoma[J]. EndocrRelat Cancer, 2008, 15(3): 801-815.
  • 2Lee JJ, Foukakis T, Hashemi J, et al. Molecular cytogenetic profilesof novel and established human anaplastic thyroid carcinomamodels[J]. Thyroid, 2007, 17(4): 289-301.
  • 3Lin J, Raoof DA, Wang Z, et al. Expression and effect of inhibitionof the ubiquitin-conjugating enzyme E2C on esophagealadenocarcinomal[J]. Neoplasia, 2006, 8(12): 1062-1071.
  • 4Berlingieri MT, Pallante P, Guida M, et al. UbcH10 expression maybe a useful tool in the prognosis of ovarian carcinomas[J]. Oncogene,2007, 26(14): 2136-2140.
  • 5Berlingieri MT, Pallante P, Sboner A, et al. UbcH10 is overexpressedin malignant breast carcinomas[J]. Eur J Cancer, 2007, 43(18):2729-2735.
  • 6Lei J, Cheng GH, Yi CL, et al. Expression of ubiquitin-conjugatingenzyme E2C/UbcH10 in astrocytic tumors[J]. Brain Res, 2008, 1201:161-166.
  • 7Donato G, Iofrida G, Lavano A, et al. Analysis of UbcHl0 expressionrepresents a useful tool for the diagnosis and therapy of astrocytictumors[J]. Clin Neuropathol, 2008, 27(4): 219-233.
  • 8Ieta K, Ojima E, Tanaka F, et al. Identification of overexpressedgenes in hepatocellular carcinoma, with special reference toubiquitin-conjugating enzyme E2C gene expression[J]. Int J Cancer,2007, 121(1): 33-38.
  • 9Chen CC, Chang TW, Chen FM, et al. Combination of multiplemRNA markers(PTTG1, Survivin, UbcH10 and TK1) in thediagnosis of Taiwan Residents patients with breast cancer by membranearray[J]. Oncology, 2006, 70(6): 438-446.
  • 10Burger AM, Seth AK. The ubiquitin-mediated protein degradationpathway in canner: therapeutic implications[J]. Eur J Cancer, 2004,40(15): 2217-2229.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部